EDGAR Filing Documents for 0001144204-16-103420

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001144204-16-103420

Filing Date

2016-05-18

Accepted

2016-05-18 17:19:17

Documents

Effectiveness Date

2016-05-18

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	v439672_defa14a.htm	DEFA14A	21328
2	GRAPHIC	coverletter_001.jpg	GRAPHIC	139078
3	GRAPHIC	coverletter_002.jpg	GRAPHIC	88119
	Complete submission text file	0001144204-16-103420.txt		335660

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: DEFA14A | Act: 34 | File No.: 001-36288 | Film No.: 161661256
SIC: 2834 Pharmaceutical Preparations